Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited has announced its 2025 Annual Meeting, which will be held as a hybrid event in Auckland and online. Key agenda items include the election of Coline McConville as a director, the re-election of Stuart McLauchlan and Mark Bloom as directors, and the authorization of Deloitte’s remuneration as the company’s auditor. These resolutions are part of EBOS’ ongoing board succession planning, aimed at enhancing governance with a diverse mix of skills, and reflect the company’s commitment to maintaining strong leadership and oversight.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a range of products and services across New Zealand and Australia. The company focuses on the distribution of healthcare, medical, and pharmaceutical products, as well as animal care products, positioning itself as a key player in these markets.
Average Trading Volume: 139,855
Technical Sentiment Signal: Sell
Current Market Cap: A$5.28B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.